Review



wnt signaling pathway inhibitors iwp 2  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    MedChemExpress wnt signaling pathway inhibitors iwp 2
    Wnt Signaling Pathway Inhibitors Iwp 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 57 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wnt signaling pathway inhibitors iwp 2/product/MedChemExpress
    Average 95 stars, based on 57 article reviews
    wnt signaling pathway inhibitors iwp 2 - by Bioz Stars, 2026-03
    95/100 stars

    Images



    Similar Products

    wnt signaling pathway inhibitors iwp 2  (MedChemExpress)
    95
    MedChemExpress wnt signaling pathway inhibitors iwp 2
    Wnt Signaling Pathway Inhibitors Iwp 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wnt signaling pathway inhibitors iwp 2/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    wnt signaling pathway inhibitors iwp 2 - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    wnt signaling pathway pharmacological inhibitor iwp-2  (Millipore)
    90
    Millipore wnt signaling pathway pharmacological inhibitor iwp-2
    <t>IWP-2</t> inhibits IL-36γ-induced expression of cyclinD1 and ki-67 in HaCaT cells. HaCaT cells were incubated with IL-36γ (100 ng/mL) for 24 h and 48 h in the presence or absence of IWP-2 (1 μM). IL-36γ exposure induced cyclinD1 and ki-67 upregulation. Treatment with IWP-2 significantly blunted IL-36γ induced cyclinD1 and ki-67 upregulation at mRNA level. ∗P < 0.05 vs. Control group; #P < 0.05 vs. IL-36γ group.
    Wnt Signaling Pathway Pharmacological Inhibitor Iwp 2, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wnt signaling pathway pharmacological inhibitor iwp-2/product/Millipore
    Average 90 stars, based on 1 article reviews
    wnt signaling pathway pharmacological inhibitor iwp-2 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    IWP-2 inhibits IL-36γ-induced expression of cyclinD1 and ki-67 in HaCaT cells. HaCaT cells were incubated with IL-36γ (100 ng/mL) for 24 h and 48 h in the presence or absence of IWP-2 (1 μM). IL-36γ exposure induced cyclinD1 and ki-67 upregulation. Treatment with IWP-2 significantly blunted IL-36γ induced cyclinD1 and ki-67 upregulation at mRNA level. ∗P < 0.05 vs. Control group; #P < 0.05 vs. IL-36γ group.

    Journal: International Journal of Medical Sciences

    Article Title: IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis

    doi: 10.7150/ijms.20809

    Figure Lengend Snippet: IWP-2 inhibits IL-36γ-induced expression of cyclinD1 and ki-67 in HaCaT cells. HaCaT cells were incubated with IL-36γ (100 ng/mL) for 24 h and 48 h in the presence or absence of IWP-2 (1 μM). IL-36γ exposure induced cyclinD1 and ki-67 upregulation. Treatment with IWP-2 significantly blunted IL-36γ induced cyclinD1 and ki-67 upregulation at mRNA level. ∗P < 0.05 vs. Control group; #P < 0.05 vs. IL-36γ group.

    Article Snippet: HaCaT cells in logarithmic phase were treated with 100 ng/ml recombinant human IL-36γ (R&D Systems, Minneapolis, MN, USA), as follow Wnt signaling pathway pharmacological inhibitor IWP-2 (Sigma, St. Louis, MO, USA) 1 μM for 30 min.

    Techniques: Expressing, Incubation

    IWP-2 inhibits IL-36γ-induced downregulation of differentiation markers in HaCaT cells. Filaggrin, involucrin, keratin 1 and keratin 5 mRNA levels in HaCaT cells were assessed by real-time PCR. HaCaT cells were incubated with IL-36γ (100 ng/mL) for 24 h and 48 h in the presence or absence of IWP-2 (1 μM). ∗P < 0.05 vs. Control group; #P < 0.05 vs. IL-36γ group.

    Journal: International Journal of Medical Sciences

    Article Title: IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis

    doi: 10.7150/ijms.20809

    Figure Lengend Snippet: IWP-2 inhibits IL-36γ-induced downregulation of differentiation markers in HaCaT cells. Filaggrin, involucrin, keratin 1 and keratin 5 mRNA levels in HaCaT cells were assessed by real-time PCR. HaCaT cells were incubated with IL-36γ (100 ng/mL) for 24 h and 48 h in the presence or absence of IWP-2 (1 μM). ∗P < 0.05 vs. Control group; #P < 0.05 vs. IL-36γ group.

    Article Snippet: HaCaT cells in logarithmic phase were treated with 100 ng/ml recombinant human IL-36γ (R&D Systems, Minneapolis, MN, USA), as follow Wnt signaling pathway pharmacological inhibitor IWP-2 (Sigma, St. Louis, MO, USA) 1 μM for 30 min.

    Techniques: Real-time Polymerase Chain Reaction, Incubation

    IWP-2 inhibits IL-36γ-induced upregulation of proinflammatory cytokines in HaCaT cells. IFN-γ, IL-1β and IL-6 levels of conditioned media were assessed by ELISA. Conditioned media were collected from HaCaT cells incubated with IL-36γ (100 ng/mL) for 24 h and 48 h in the presence or absence of IWP-2 (1 μM). ∗P < 0.05 vs. Control group; #P < 0.05 vs. IL-36γ group.

    Journal: International Journal of Medical Sciences

    Article Title: IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis

    doi: 10.7150/ijms.20809

    Figure Lengend Snippet: IWP-2 inhibits IL-36γ-induced upregulation of proinflammatory cytokines in HaCaT cells. IFN-γ, IL-1β and IL-6 levels of conditioned media were assessed by ELISA. Conditioned media were collected from HaCaT cells incubated with IL-36γ (100 ng/mL) for 24 h and 48 h in the presence or absence of IWP-2 (1 μM). ∗P < 0.05 vs. Control group; #P < 0.05 vs. IL-36γ group.

    Article Snippet: HaCaT cells in logarithmic phase were treated with 100 ng/ml recombinant human IL-36γ (R&D Systems, Minneapolis, MN, USA), as follow Wnt signaling pathway pharmacological inhibitor IWP-2 (Sigma, St. Louis, MO, USA) 1 μM for 30 min.

    Techniques: Enzyme-linked Immunosorbent Assay, Incubation

    IWP-2 inhibits IL-36γ-induced expression of β-catenin in HaCaT cells. HaCaT cells were incubated with IL-36γ (100 ng/mL) for 24 h and 48 h in the presence or absence of IWP-2 (1 μM). IL-36γ exposure induced β-catenin upregulation. Treatment with IWP-2 significantly blunted IL-36γ induced β-catenin upregulation at mRNA level. ∗P < 0.05 vs. Control group; #P < 0.05 vs. IL-36γ group.

    Journal: International Journal of Medical Sciences

    Article Title: IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis

    doi: 10.7150/ijms.20809

    Figure Lengend Snippet: IWP-2 inhibits IL-36γ-induced expression of β-catenin in HaCaT cells. HaCaT cells were incubated with IL-36γ (100 ng/mL) for 24 h and 48 h in the presence or absence of IWP-2 (1 μM). IL-36γ exposure induced β-catenin upregulation. Treatment with IWP-2 significantly blunted IL-36γ induced β-catenin upregulation at mRNA level. ∗P < 0.05 vs. Control group; #P < 0.05 vs. IL-36γ group.

    Article Snippet: HaCaT cells in logarithmic phase were treated with 100 ng/ml recombinant human IL-36γ (R&D Systems, Minneapolis, MN, USA), as follow Wnt signaling pathway pharmacological inhibitor IWP-2 (Sigma, St. Louis, MO, USA) 1 μM for 30 min.

    Techniques: Expressing, Incubation